Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of 1.81 million. The enterprise value is -2.74 million.
| Market Cap | 1.81M |
| Enterprise Value | -2.74M |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 3.18 million shares outstanding. The number of shares has increased by 620.95% in one year.
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | +620.95% |
| Shares Change (QoQ) | +56.75% |
| Owned by Insiders (%) | 0.71% |
| Owned by Institutions (%) | 3.15% |
| Float | 2.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.29 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.67 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13
| Current Ratio | 3.13 |
| Quick Ratio | 3.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -185.46% and return on invested capital (ROIC) is -119.37%.
| Return on Equity (ROE) | -185.46% |
| Return on Assets (ROA) | -86.88% |
| Return on Invested Capital (ROIC) | -119.37% |
| Return on Capital Employed (ROCE) | -224.54% |
| Revenue Per Employee | 702,000 |
| Profits Per Employee | -821,500 |
| Employee Count | 2 |
| Asset Turnover | 0.31 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.75% in the last 52 weeks. The beta is -0.00, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -77.75% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.96 |
| Relative Strength Index (RSI) | 62.70 |
| Average Volume (20 Days) | 10,526 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATXI had revenue of 1.40 million and -1.64 million in losses. Loss per share was -0.68.
| Revenue | 1.40M |
| Gross Profit | 1.40M |
| Operating Income | -6.36M |
| Pretax Income | -6.18M |
| Net Income | -1.64M |
| EBITDA | n/a |
| EBIT | -6.36M |
| Loss Per Share | -0.68 |
Balance Sheet
The company has 3.33 million in cash and n/a in debt, giving a net cash position of 3.33 million or 1.04 per share.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | n/a |
| Net Cash | 3.33M |
| Net Cash Per Share | 1.04 |
| Equity (Book Value) | 2.83M |
| Book Value Per Share | 1.27 |
| Working Capital | 2.83M |
Cash Flow
| Operating Cash Flow | -5.02M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -452.92% |
| Pretax Margin | -439.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -620.95% |
| Shareholder Yield | n/a |
| Earnings Yield | -90.54% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.0133333.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0133333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |